Molmed, l'Opa giapponese in bilico per golden power - ilGiornale.it
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Will MolMed soon have its first Cell therapy on the Market?
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed - YouTube
IPO e altre ammissioni - 2008 - Borsa Italiana
Will MolMed soon have its first Cell therapy on the Market?
COMUNICATO STAMPA
Meeting agenda | molmed
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
MolMed now part of AGC Biologics | Iterate.ai
MolMed to test the health of the European sector | Evaluate
Indici di Borsa in tempo reale: quotazioni e titoli - Borsa Italiana
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
MOLMED S.P.A.: azionisti, dirigenti e profilo società | MLM | IT0001080248 | MarketScreener
Azioni Molmed: ha ragione Banca Imi o il mercato?
COMUNICATO STAMPA
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
Relazione sulla remunerazione Molecular Medicine S.p.A.
MolMed 06
Relazione sulla Remunerazione MolMed S.p.A.
